Loading...
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
BACKGROUND: Hereditary angioedema is characterized by recurrent attacks of angioedema of the skin, larynx, and gastrointestinal tract. Bradykinin is the key mediator of symptoms. Icatibant is a selective bradykinin B2 receptor antagonist. METHODS: In two double-blind, randomized, multicenter trials,...
Na minha lista:
| Udgivet i: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662377/ https://ncbi.nlm.nih.gov/pubmed/20818888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0906393 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|